{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:40:57Z","timestamp":1792640457921,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["BFU2017-83934-P"],"award-info":[{"award-number":["BFU2017-83934-P"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-118660GB-I00"],"award-info":[{"award-number":["PID2020-118660GB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PIE14-00005"],"award-info":[{"award-number":["PIE14-00005"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52898-y","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T09:02:22Z","timestamp":1727773342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1010-5012","authenticated-orcid":false,"given":"Miguel A.","family":"S\u00e1nchez-Garrido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Serrano-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ruiz-Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rodr\u00edguez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarnaci\u00f3n","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Chicano-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6662-2932","authenticated-orcid":false,"given":"Marina","family":"Mora-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9633-2805","authenticated-orcid":false,"given":"Claes","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Poutanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gayt\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Douros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo D.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-4085","authenticated-orcid":false,"given":"Richard D.","family":"DiMarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-371X","authenticated-orcid":false,"given":"Matthias H.","family":"Tsch\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-5567","authenticated-orcid":false,"given":"Manuel","family":"Tena-Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"52898_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/humupd\/dmz029","volume":"25","author":"R Wang","year":"2019","unstructured":"Wang, R. et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum. Reprod. Update 25, 717\u2013732 (2019).","journal-title":"Hum. Reprod. Update"},{"key":"52898_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"NS Kakoly","year":"2018","unstructured":"Kakoly, N. S. et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum. Reprod. Update 24, 455\u2013467 (2018).","journal-title":"Hum. Reprod. Update"},{"key":"52898_CR3","doi-asserted-by":"publisher","first-page":"96351","DOI":"10.18632\/oncotarget.19180","volume":"8","author":"T Ding","year":"2017","unstructured":"Ding, T. et al. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget 8, 96351\u201396358 (2017).","journal-title":"Oncotarget"},{"key":"52898_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0889-8529(03)00044-6","volume":"32","author":"S Franks","year":"2003","unstructured":"Franks, S. Assessment and management of anovulatory infertility in polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 32, 639\u2013651 (2003).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"52898_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido, M. A. & Tena-Sempere, M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol. Metab. 35, 100937 (2020).","journal-title":"Mol. Metab."},{"key":"52898_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/cen.13828","volume":"89","author":"EW Gilbert","year":"2018","unstructured":"Gilbert, E. W., Tay, C. T., Hiam, D. S., Teede, H. J. & Moran, L. J. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin. Endocrinol. 89, 683\u2013699 (2018).","journal-title":"Clin. Endocrinol."},{"key":"52898_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber, T. M. & Franks, S. Obesity and polycystic ovary syndrome. Clin. Endocrinol. 95, 531\u2013541 (2021).","journal-title":"Clin. Endocrinol."},{"key":"52898_CR8","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/humrep\/dex308","volume":"32","author":"F Tosi","year":"2017","unstructured":"Tosi, F., Bonora, E. & Moghetti, P. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum. Reprod. 32, 2515\u20132521 (2017).","journal-title":"Hum. Reprod."},{"key":"52898_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans, S. M. & Pate, K. A. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin. Epidemiol. 6, 1\u201313 (2013).","journal-title":"Clin. Epidemiol."},{"key":"52898_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","volume":"122","author":"CG Baptiste","year":"2010","unstructured":"Baptiste, C. G., Battista, M. C., Trottier, A. & Baillargeon, J. P. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J. Steroid Biochem. Mol. Biol. 122, 42\u201352 (2010).","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"52898_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.repbio.2015.12.006","volume":"16","author":"D Cadagan","year":"2016","unstructured":"Cadagan, D., Khan, R. & Amer, S. Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome. Reprod. Biol. 16, 53\u201360 (2016).","journal-title":"Reprod. Biol."},{"key":"52898_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrendo.2014.102","volume":"10","author":"CN Jayasena","year":"2014","unstructured":"Jayasena, C. N. & Franks, S. The management of patients with polycystic ovary syndrome. Nat. Rev. Endocrinol. 10, 624\u2013636 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"52898_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/20420188221113140","volume":"13","author":"T McDonnell","year":"2022","unstructured":"McDonnell, T., Cussen, L., McIlroy, M. & O\u2019Reilly, M. W. Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 13, 20420188221113140 (2022).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"52898_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu, Y. & Qiao, J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J. Healthc. Eng. 2022, 9240569 (2022).","journal-title":"J. Healthc. Eng."},{"key":"52898_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","volume":"36","author":"DS Kiddy","year":"1992","unstructured":"Kiddy, D. S. et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. 36, 105\u2013111 (1992).","journal-title":"Clin. Endocrinol."},{"key":"52898_CR16","first-page":"1470","volume":"84","author":"MM Huber-Buchholz","year":"1999","unstructured":"Huber-Buchholz, M. M., Carey, D. G. & Norman, R. J. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J. Clin. Endocrinol. Metab. 84, 1470\u20131474 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52898_CR17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3109\/09513590.2010.491572","volume":"26","author":"D Glintborg","year":"2010","unstructured":"Glintborg, D. & Andersen, M. Thiazolinedione treatment in PCOS\u2013an update. Gynecol. Endocrinol. 26, 791\u2013803 (2010).","journal-title":"Gynecol. Endocrinol."},{"key":"52898_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/1389201015666140330195142","volume":"15","author":"N Nathan","year":"2014","unstructured":"Nathan, N. & Sullivan, S. D. The utility of metformin therapy in reproductive-aged women with polycystic ovary syndrome (PCOS). Curr. Pharm. Biotechnol. 15, 70\u201383 (2014).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"52898_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ajog.2008.09.010","volume":"199","author":"R Mathur","year":"2008","unstructured":"Mathur, R., Alexander, C. J., Yano, J., Trivax, B. & Azziz, R. Use of metformin in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 199, 596\u2013609 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"52898_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMct0707092","volume":"358","author":"JE Nestler","year":"2008","unstructured":"Nestler, J. E. Metformin for the treatment of the polycystic ovary syndrome. N. Engl. J. Med. 358, 47\u201354 (2008).","journal-title":"N. Engl. J. Med."},{"key":"52898_CR21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/1933719109340925","volume":"16","author":"M Aubuchon","year":"2009","unstructured":"Aubuchon, M. et al. Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS). Reprod. Sci. 16, 938\u2013946 (2009).","journal-title":"Reprod. Sci."},{"key":"52898_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1365-2125.2002.01575.x","volume":"53","author":"ND Sturrock","year":"2002","unstructured":"Sturrock, N. D., Lannon, B. & Fay, T. N. Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br. J. Clin. Pharmacol. 53, 469\u2013473 (2002).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"52898_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","volume":"356","author":"RS Legro","year":"2007","unstructured":"Legro, R. S. et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 356, 551\u2013566 (2007).","journal-title":"N. Engl. J. Med."},{"key":"52898_CR24","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1210\/jc.2005-0110","volume":"90","author":"S Palomba","year":"2005","unstructured":"Palomba, S. et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90, 4068\u20134074 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52898_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/2042018810380215","volume":"1","author":"H Lashen","year":"2010","unstructured":"Lashen, H. Role of metformin in the management of polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 1, 117\u2013128 (2010).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"52898_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD Muller","year":"2019","unstructured":"Muller, T. D. et al. Glucagon-like peptide 1 (GLP-1). Mol. Metab. 30, 72\u2013130 (2019).","journal-title":"Mol. Metab."},{"key":"52898_CR27","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jdiacomp.2016.05.016","volume":"30","author":"GE Fava","year":"2016","unstructured":"Fava, G. E., Dong, E. W. & Wu, H. Intra-islet glucagon-like peptide 1. J. Diabetes Complications 30, 1651\u20131658 (2016).","journal-title":"J. Diabetes Complications"},{"key":"52898_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/17512433.2017.1292125","volume":"10","author":"EM Lamos","year":"2017","unstructured":"Lamos, E. M., Malek, R. & Davis, S. N. GLP-1 receptor agonists in the treatment of polycystic ovary syndrome. Expert. Rev. Clin. Pharmacol. 10, 401\u2013408 (2017).","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"52898_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fendo.2014.00140","volume":"5","author":"CB Rasmussen","year":"2014","unstructured":"Rasmussen, C. B. & Lindenberg, S. The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study. Front. Endocrinol. 5, 140 (2014).","journal-title":"Front. Endocrinol."},{"key":"52898_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF03401383","volume":"14","author":"M Jensterle","year":"2015","unstructured":"Jensterle, M., Kravos, N. A., Pfeifer, M., Kocjan, T. & Janez, A. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome. Hormones 14, 81\u201390 (2015).","journal-title":"Hormones"},{"key":"52898_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","volume":"39","author":"Y Han","year":"2019","unstructured":"Han, Y., Li, Y. & He, B. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod. Biomed. Online 39, 332\u2013342 (2019).","journal-title":"Reprod. Biomed. Online"},{"key":"52898_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","volume":"14","author":"M Siamashvili","year":"2021","unstructured":"Siamashvili, M. & Davis, S. N. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. Expert. Rev. Clin. Pharmacol. 14, 1081\u20131089 (2021).","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"52898_CR33","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/nm.3009","volume":"18","author":"B Finan","year":"2012","unstructured":"Finan, B. et al. Targeted estrogen delivery reverses the metabolic syndrome. Nat. Med. 18, 1847\u20131856 (2012).","journal-title":"Nat. Med."},{"key":"52898_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm.3761","volume":"21","author":"B Finan","year":"2015","unstructured":"Finan, B. et al. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. Nat. Med. 21, 27\u201336 (2015).","journal-title":"Nat. Med."},{"key":"52898_CR35","doi-asserted-by":"publisher","first-page":"209ra151","DOI":"10.1126\/scitranslmed.3007218","volume":"5","author":"B Finan","year":"2013","unstructured":"Finan, B. et al. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci. Transl. Med. 5, 209ra151 (2013).","journal-title":"Sci. Transl. Med."},{"key":"52898_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rmb2.12262","volume":"18","author":"S Osuka","year":"2019","unstructured":"Osuka, S. et al. Animal models of polycystic ovary syndrome: a review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod. Med. Biol. 18, 151\u2013160 (2019).","journal-title":"Reprod. Med. Biol."},{"key":"52898_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.950105","volume":"13","author":"J Ren","year":"2022","unstructured":"Ren, J. et al. The PNA mouse may be the best animal model of polycystic ovary syndrome. Front. Endocrinol. 13, 950105 (2022).","journal-title":"Front. Endocrinol."},{"key":"52898_CR38","doi-asserted-by":"publisher","unstructured":"Stener-Victorin, E. et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr. Rev. https:\/\/doi.org\/10.1210\/endrev\/bnaa010 (2020).","DOI":"10.1210\/endrev\/bnaa010"},{"key":"52898_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100123","volume":"12","author":"L Barrea","year":"2021","unstructured":"Barrea, L. et al. PCOS and nutritional approaches: differences between lean and obese phenotype. Metabol. Open 12, 100123 (2021).","journal-title":"Metabol. Open"},{"key":"52898_CR40","doi-asserted-by":"publisher","unstructured":"Chudzicka-Strugala, I., Golebiewska, I., Banaszewska, B., Brudecki, G. & Zwozdziak, B. The role of individually selected diets in obese women with PCOS-a review. Nutrients https:\/\/doi.org\/10.3390\/nu14214555 (2022).","DOI":"10.3390\/nu14214555"},{"key":"52898_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/dom.14215","volume":"23","author":"S Sachs","year":"2021","unstructured":"Sachs, S. et al. Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice. Diabetes Obes. Metab. 23, 195\u2013207 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"52898_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.molmet.2017.02.002","volume":"6","author":"S Jall","year":"2017","unstructured":"Jall, S. et al. Monomeric GLP-1\/GIP\/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice. Mol. Metab. 6, 440\u2013446 (2017).","journal-title":"Mol. Metab."},{"key":"52898_CR43","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/dom.14663","volume":"24","author":"M Ghidewon","year":"2022","unstructured":"Ghidewon, M. et al. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms. Diabetes Obes. Metab. 24, 1010\u20131020 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"52898_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","volume":"31","author":"T Borner","year":"2020","unstructured":"Borner, T. et al. GDF15 induces anorexia through nausea and emesis. Cell Metab. 31, 351\u2013362 e355 (2020).","journal-title":"Cell Metab."},{"key":"52898_CR45","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede, H. J. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 33, 1602\u20131618 (2018).","journal-title":"Hum. Reprod."},{"key":"52898_CR46","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/humrep\/dez205","volume":"34","author":"A Romero-Ruiz","year":"2019","unstructured":"Romero-Ruiz, A. et al. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome. Hum. Reprod. 34, 2495\u20132512 (2019).","journal-title":"Hum. Reprod."},{"key":"52898_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff, A. M. et al. Tirzepatide once weekly for the treatment of obesity. N. Engl. J. Med. 387, 205\u2013216 (2022).","journal-title":"N. Engl. J. Med."},{"key":"52898_CR48","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00125-014-3478-3","volume":"58","author":"RW Schwenk","year":"2015","unstructured":"Schwenk, R. W. et al. GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice. Diabetologia 58, 604\u2013614 (2015).","journal-title":"Diabetologia"},{"key":"52898_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","volume":"134","author":"S Wharton","year":"2022","unstructured":"Wharton, S. et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad. Med. 134, 14\u201319 (2022).","journal-title":"Postgrad. Med."},{"key":"52898_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep10211","volume":"5","author":"JP Tiano","year":"2015","unstructured":"Tiano, J. P., Tate, C. R., Yang, B. S., DiMarchi, R. & Mauvais-Jarvis, F. Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis. Sci. Rep. 5, 10211 (2015).","journal-title":"Sci. Rep."},{"key":"52898_CR51","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2016.07.039","volume":"110","author":"H Vogel","year":"2016","unstructured":"Vogel, H. et al. GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight. Neuropharmacology 110, 396\u2013406 (2016).","journal-title":"Neuropharmacology"},{"key":"52898_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2012-1055","volume":"34","author":"F Mauvais-Jarvis","year":"2013","unstructured":"Mauvais-Jarvis, F., Clegg, D. J. & Hevener, A. L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 34, 309\u2013338 (2013).","journal-title":"Endocr. Rev."},{"key":"52898_CR53","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1210\/en.2014-1342","volume":"155","author":"SA Litwak","year":"2014","unstructured":"Litwak, S. A. et al. Estradiol prevents fat accumulation and overcomes leptin resistance in female high-fat diet mice. Endocrinology 155, 4447\u20134460 (2014).","journal-title":"Endocrinology"},{"key":"52898_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31783-6","volume":"13","author":"KD Acharya","year":"2023","unstructured":"Acharya, K. D. et al. Estradiol-mediated protection against high-fat diet induced anxiety and obesity is associated with changes in the gut microbiota in female mice. Sci. Rep. 13, 4776 (2023).","journal-title":"Sci. Rep."},{"key":"52898_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13293-016-0059-9","volume":"7","author":"JE Richard","year":"2016","unstructured":"Richard, J. E., Anderberg, R. H., Lopez-Ferreras, L., Olandersson, K. & Skibicka, K. P. Sex and estrogens alter the action of glucagon-like peptide-1 on reward. Biol. Sex Differ. 7, 6 (2016).","journal-title":"Biol. Sex Differ."},{"key":"52898_CR56","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5455\/medarh.2017.71.380-384","volume":"71","author":"Y Murai","year":"2017","unstructured":"Murai, Y. et al. Assessment of pharmacological responses to an anti-diabetic drug in a new obese type 2 diabetic rat model. Med. Arch. 71, 380\u2013384 (2017).","journal-title":"Med. Arch."},{"key":"52898_CR57","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1292\/jvms.18-0119","volume":"80","author":"Y Toriniwa","year":"2018","unstructured":"Toriniwa, Y. et al. Investigation of pharmacological responses to anti-diabetic drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis (NASH) model. J. Vet. Med. Sci. 80, 878\u2013885 (2018).","journal-title":"J. Vet. Med. Sci."},{"key":"52898_CR58","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1210\/en.2010-0823","volume":"152","author":"AV Roland","year":"2011","unstructured":"Roland, A. V. & Moenter, S. M. Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood. Endocrinology 152, 618\u2013628 (2011).","journal-title":"Endocrinology"},{"key":"52898_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI88878","volume":"127","author":"A Jais","year":"2017","unstructured":"Jais, A. & Bruning, J. C. Hypothalamic inflammation in obesity and metabolic disease. J. Clin. Invest. 127, 24\u201332 (2017).","journal-title":"J. Clin. Invest."},{"key":"52898_CR60","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/jcp.26909","volume":"234","author":"R Marinho","year":"2018","unstructured":"Marinho, R. et al. Endurance training prevents inflammation and apoptosis in hypothalamic neurons of obese mice. J. Cell Physiol. 234, 880\u2013890 (2018).","journal-title":"J. Cell Physiol."},{"key":"52898_CR61","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41420-021-00732-5","volume":"7","author":"X Li","year":"2021","unstructured":"Li, X. et al. Metformin attenuates hypothalamic inflammation via downregulation of RIPK1-independent microglial necroptosis in diet-induced obese mice. Cell Death Discov. 7, 338 (2021).","journal-title":"Cell Death Discov."},{"key":"52898_CR62","doi-asserted-by":"publisher","first-page":"e5045","DOI":"10.1371\/journal.pone.0005045","volume":"4","author":"JC Moraes","year":"2009","unstructured":"Moraes, J. C. et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS ONE 4, e5045 (2009).","journal-title":"PLoS ONE"},{"key":"52898_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cmet.2011.06.008","volume":"14","author":"S Kaushik","year":"2011","unstructured":"Kaushik, S. et al. Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab. 14, 173\u2013183 (2011).","journal-title":"Cell Metab."},{"key":"52898_CR64","doi-asserted-by":"publisher","first-page":"32324","DOI":"10.1074\/jbc.M111.254417","volume":"286","author":"Q Meng","year":"2011","unstructured":"Meng, Q. & Cai, D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)\/NF-kappaB pathway. J. Biol. Chem. 286, 32324\u201332332 (2011).","journal-title":"J. Biol. Chem."},{"key":"52898_CR65","doi-asserted-by":"publisher","unstructured":"Pietrocola, F. & Bravo-San Pedro, J. M. Targeting autophagy to counteract obesity-associated oxidative stress. Antioxidants https:\/\/doi.org\/10.3390\/antiox10010102 (2021).","DOI":"10.3390\/antiox10010102"},{"key":"52898_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2008.02.011","volume":"7","author":"KA Anderson","year":"2008","unstructured":"Anderson, K. A. et al. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 7, 377\u2013388 (2008).","journal-title":"Cell Metab."},{"key":"52898_CR67","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1210\/en.2014-1978","volume":"156","author":"V Outeirino-Iglesias","year":"2015","unstructured":"Outeirino-Iglesias, V., Romani-Perez, M., Gonzalez-Matias, L. C., Vigo, E. & Mallo, F. GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats. Endocrinology 156, 4226\u20134237 (2015).","journal-title":"Endocrinology"},{"key":"52898_CR68","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10815-022-02429-9","volume":"39","author":"ALG Notaro","year":"2022","unstructured":"Notaro, A. L. G. & Neto, F. T. L. The use of metformin in women with polycystic ovary syndrome: an updated review. J. Assist. Reprod. Genet. 39, 573\u2013579 (2022).","journal-title":"J. Assist. Reprod. Genet."},{"key":"52898_CR69","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejogrb.2022.01.025","volume":"271","author":"R Magzoub","year":"2022","unstructured":"Magzoub, R., Kheirelseid, E. A. H., Perks, C. & Lewis, S. Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 271, 38\u201362 (2022).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"52898_CR70","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"AS Caldwell","year":"2014","unstructured":"Caldwell, A. S. et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155, 3146\u20133159 (2014).","journal-title":"Endocrinology"},{"key":"52898_CR71","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661 (2008).","journal-title":"FASEB J."},{"key":"52898_CR72","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1210\/en.2014-1765","volume":"156","author":"M Di Pietro","year":"2015","unstructured":"Di Pietro, M. et al. Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model. Endocrinology 156, 1453\u20131463 (2015).","journal-title":"Endocrinology"},{"key":"52898_CR73","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll, A. P. et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444\u2013448 (2020).","journal-title":"Nature"},{"key":"52898_CR74","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s42255-020-0171-3","volume":"2","author":"S Sachs","year":"2020","unstructured":"Sachs, S. et al. Targeted pharmacological therapy restores beta-cell function for diabetes remission. Nat. Metab. 2, 192\u2013209 (2020).","journal-title":"Nat. Metab."},{"key":"52898_CR75","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"52898_CR76","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1210\/en.2013-1502","volume":"154","author":"FJ Steyn","year":"2013","unstructured":"Steyn, F. J. et al. Development of a methodology for and assessment of pulsatile luteinizing hormone secretion in juvenile and adult male mice. Endocrinology 154, 4939\u20134945 (2013).","journal-title":"Endocrinology"},{"key":"52898_CR77","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0031-9384(76)90171-2","volume":"17","author":"D Mitchell","year":"1976","unstructured":"Mitchell, D. et al. Poison induced pica in rats. Physiol. Behav. 17, 691\u2013697 (1976).","journal-title":"Physiol. Behav."},{"key":"52898_CR78","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1210\/clinem\/dgab867","volume":"107","author":"C Ohlsson","year":"2022","unstructured":"Ohlsson, C. et al. Low progesterone and low estradiol levels associate with abdominal aortic aneurysms in men. J. Clin. Endocrinol. Metab. 107, e1413\u2013e1425 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"52898_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/srep46381","volume":"7","author":"F Gaytan","year":"2017","unstructured":"Gaytan, F. et al. Development and validation of a method for precise dating of female puberty in laboratory rodents: the puberty ovarian maturation score (Pub-Score). Sci. Rep. 7, 46381 (2017).","journal-title":"Sci. Rep."},{"key":"52898_CR80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel, D. & Flugge, U. I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141\u2013143 (1984).","journal-title":"Anal. Biochem."},{"key":"52898_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72664-6","volume":"10","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., Wong, L. & Goh, W. W. B. How to do quantile normalization correctly for gene expression data analyses. Sci. Rep. 10, 15534 (2020).","journal-title":"Sci. Rep."},{"key":"52898_CR82","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/00045632211050531","volume":"59","author":"RM West","year":"2022","unstructured":"West, R. M. Best practice in statistics: the use of log transformation. Ann. Clin. Biochem. 59, 162\u2013165 (2022).","journal-title":"Ann. Clin. Biochem."},{"key":"52898_CR83","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"52898_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1559-2","volume":"18","author":"A Fabregat","year":"2017","unstructured":"Fabregat, A. et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinformatics 18, 142 (2017).","journal-title":"BMC Bioinformatics"},{"key":"52898_CR85","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia, J., Psychogios, N., Young, N. & Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652\u2013660 (2009).","journal-title":"Nucleic Acids Res."},{"key":"52898_CR86","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52898-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T10:06:52Z","timestamp":1727777212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52898-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52898"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52898-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.F., J.D.D., and B.Y. are former employees of Novo Nordisk. T.D.M. received funding from Novo Nordisk and speaking fees within the last 3 years from Novo Nordisk, Eli Lilly, Astra Zeneca, and Berlin Chemie AG. M.H.T. is a member of the SAB of ERX Pharmaceuticals, Inc. (last SAB meeting in 2019). Since 2018, he has served as the CSO and CEO of Helmholtz Munich (an academic research center with ca. 2500 scientists and staff). Helmholtz Munich is involved in numerous collaborations with a multitude of companies and institutions, worldwide. Cooperation, at times, involves research funding and includes (but are not limited to) interactions with e.g., Novo Nordisk, Boehringer Ingelheim, Roche Diagnostics, Arbormed, SCG Cell Therapy, and others. None of the above funding sources were involved in the preparation of this paper. M.T.S. has participated in the last 3 years in projects from Novo Nordisk and collaborated via grant agreements with the company Oxo-Life Ltd. (Barcelona, Spain), addressing therapeutic strategies for PCOS, although no connection exists between these projects\/agreements and the present work. The rest of the authors have no conflict of interest to disclose in relation to the contents of this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8498"}}